PSD psivida limited

US pharmaceuticals group Alimera Sciences has thrown...

  1. futbolista
    157 Posts.
    clock Created with Sketch.
    17/03/08
    09:36
    Post #: 3476171
    US pharmaceuticals group Alimera Sciences has thrown Perth-founded biotech pSivida a lifeline by agreeing to amend its licence and collaboration deal by taking an extra 30 per cent stake, delivering the cash strapped outfit up to $83 million over four years.
    PSD Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

I88 Major fault system and magnetic anomalies discovered at Talus Uranium Prospect
right-arrow Created with Sketch.
AMI First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia
right-arrow Created with Sketch.
MCT Metalicity looking for offers on Admiral Bay zinc project
right-arrow Created with Sketch.
GNX NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PSD (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.